Abstract
An increase in the number of aged patients with cutaneous lymphomas has resulted in a difficulty in the treatment of these disorders. In particular, we have increasing numbers of aged patients with primary cutaneous anaplastic large cell lymphoma, cutaneous B cell lymphoma, adult T cell leukemia/ lymphoma, Sézary syndrome, and mycosis fungoides. The therapeutic options for these lymphomas include etoposide, interferon-γ, radiation, steroid pulse therapy, and THP-COP. According to the characteristics of each treatment and depending on the patients' general conditions, dermatologists should choose one or more of these therapeutic modalities to obtain a good result without severe side effects. [Skin Cancer (Japan) 2006; 21: 261-267]
